KCAS-blog-thumb_2024-010_The What_ Blogs
Read article Expanding Our Clinical Reach with Spectral Flow Cytometry

We are thrilled to announce a major milestone in the evolution of our global clinical support services. After months of detailed planning, collaboration, and execution, we’ve successfully integrated spectral flow cytometry at our KCAS Bio sites in Philadelphia, PA, USA; Lyon, France; and Crux Biolabs, our…

KCAS-blog-thumb_2024-09_Elevate-Your-Drug-Development Blogs
Read article Partner with KCAS Bio for Expert Clinical Sample Kitting

Clinical sample kitting plays a vital role in drug development projects. It requires meticulous attention to detail and the experience necessary to ensure that each kit is crafted according to precise specifications. A well-organized clinical kit can be the difference between smooth operations and costly delays. At KCAS Bio, we…

KCAS-blog-thumb_2024-09_USevents1 Blogs
Read article KCAS Bio’s Autumn 2024 Conferences

KCAS Bio is excited to announce our participation in several premier conferences throughout the United States this fall. These events bring together experts, innovators, and leaders in pharmaceuticals, biotechnology, and clinical research to exchange insights, explore the latest technologies, and drive the future of scientific discovery. As a trusted provider…

KCAS-blog-thumb_2024-09_LyonEmailBlog Blogs
Read article KCAS Bio Attending a Series of Premier Global Conferences in 2024

KCAS Bio is excited to announce our participation in several key conferences throughout the world. These events present invaluable opportunities for collaboration, innovation, and the sharing of industry insights. As a leading provider of bioanalytical services, KCAS Bio is committed to engaging with thought leaders, scientists, and professionals worldwide to…

KCAS-podcast-thumb_TCF-012 Podcasts
Listen to podcast Podcast (The Conversational Flow) Eps #12: “High Content Analysis: Finding Needles in a Growing Haystack”

In the 12th episode of “The Conversational Flow” podcast, Brian and Adam welcome two special guests – Sean Burke of Denovo Software and Ryan Brinkman of Dotmatics – who join them to discuss the answers to a number of specific questions about High Content Analysis: How can we manage and…

KCAS-blog-thumb_2024-09_Understanding ADA Assays Blogs
Read article Understanding Anti-Drug Antibody (ADA) Assays: The Key to Immunogenicity in Preclinical Drug Development

In both preclinical and clinical studies, evaluating immunogenicity—an immune system’s response to a foreign substance—is a critical factor. Anti-drug antibody (ADA) assays play a pivotal role in this evaluation, helping researchers and pharmaceutical companies determine how the immune system reacts to therapeutic drugs. But what exactly is immunogenicity? Simply put,…

KCAS-event-thumb_2024-09_ICCS October 4 - October 8

KCAS Bio is excited to announce our participation in the 39th International Clinical Cytometry Meeting and Course (ICCS), taking place in Seattle, Washington. This prestigious event will bring together global experts in cytometry to explore the latest advancements in clinical applications, research, and innovation. As a leader in bioanalytical services,…

KCAS-event-thumb_2024-09_BioJapan October 9 - October 11

KCAS Bio is thrilled to participate in BioJapan 2024, one of Asia’s most prominent biotechnology events, held in Yokohama, Japan. As a leader in bioanalytical and contract research services, our presence at BioJapan underscores our commitment to providing world-class solutions to the global biotech industry. This event offers an unparalleled…

KCAS-blog-thumb_2024-09_Pharmacokinetics Blogs
Read article The Importance of Pharmacokinetics in Drug Development

The Role of Pharmacokinetics (PK) in Drug R&D Pharmacokinetics (PK) is defined as the study of the fate of a new therapeutic entity (NTE) after it is administered into the body of animals or humans. It involves understanding how the drug is absorbed, distributed, metabolized, and eliminated (ADME). Essentially, PK…

KCAS-webinar-thumb_2024-09_Hybrid LC-MS_MS Webinars
View webinar Hybrid LC-MS/MS Technology Becoming the New Norm in the Bioanalysis of Antibody-Drug Conjugates

As the pharmaceutical industry continues to evolve, so does the technology behind drug development. One of the most groundbreaking advancements in bioanalysis is Hybrid LC-MS/MS technology, which is rapidly becoming the new standard for analyzing Antibody Drug Conjugates (ADCs). KCAS Bio is proud to be at the forefront of this…

KCAS-event-thumb_2024-09_AusBiotech October 30 - November 1

KCAS Bio is excited to announce our attendance at AusBiotech 2024 in Melbourne, Australia. As a leader in bioanalytical services, we are committed to supporting the growth and innovation of the biotech industry. This premier event offers a unique platform to engage with industry experts, innovators, and decision-makers, all working…